Table 2. Association between PCDH7 expression and clinicopathologic features in NMIBC patients (n = 199).
| Features | Variables | No. (%) | PCDH7 Expression | P | |
|---|---|---|---|---|---|
| High | Low | ||||
| Age (years) | ≤ 65 | 74 (37.2) | 36 (48.6) | 38 (51.4) | 0.157 |
| Sex | > 65 | 125 (62.8) | 48 (42.2) | 77 (57.8) | |
| Tumor size (cm) | Male | 138 (69.3) | 62 (44.9) | 76 (55.1) | 0.243 |
| Tumor number | Female | 61 (30.7) | 22 (36.1) | 39 (63.9) | |
| Grade | ≤ 3 | 109 (54.8) | 53 (48.6) | 56 (51.4) | 0.044 |
| Stage | > 3 | 90 (45.2) | 31 (34.4) | 59 (65.6) | |
| Single | 114 (57.3) | 49 (43.0) | 65 (57.0) | 0.799 | |
| Multiple | 85 (42.7) | 35 (41.2) | 50 (58.8) | ||
| G1 | 70 (35.2) | 35 (50.0) | 35 (50.0) | 0.021 | |
| G2 | 65 (32.7) | 31 (47.7) | 34 (52.3) | ||
| G3 | 64 (32.1) | 18 (28.1) | 46 (71.9) | ||
| Ta | 72 (36.2) | 32 (44.4) | 40 (55.6) | 0.631 | |
| T1 | 127 (63.8) | 52 (40.9) | 75 (59.1) | ||